Indeed, a seminal investigation showing the efficacy of statin use in reducing recurrent ischemic events in unstable angina patients found that the benefits of statin therapy were highly dependent on the presence of an initial CD4+CD28null T-cell expansion (3). The gene discussed is CD4; the disease is angina pectoris.